| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 12/12/2002 | US20020187523 Extracellular signaling molecules |
| 12/12/2002 | US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation |
| 12/12/2002 | US20020187209 Anti-ulcer pharmaceutical composition and the preparation thereof |
| 12/12/2002 | US20020187181 System for delivering cosmetics and pharmaceuticals |
| 12/12/2002 | US20020187152 Administering a drug which can selectively kill Fusobacterium varium cells, or a drug which can neutralize the toxin produced by Fusobacterium varium cells; vaccines, diagnosis, screening |
| 12/12/2002 | US20020187134 Prebiotic and probiotic compositions and methods for their use in gut-based therapies |
| 12/12/2002 | CA2449771A1 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 12/12/2002 | CA2449770A1 Novel anti-infectives |
| 12/12/2002 | CA2449175A1 Use of methylnaltrexone to treat immune suppression |
| 12/12/2002 | CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/12/2002 | CA2449097A1 5-ethyl-imidazotriazinones |
| 12/12/2002 | CA2448606A1 Nucleic acid-associated proteins |
| 12/12/2002 | CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 12/12/2002 | CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 12/12/2002 | CA2445460A1 Carboline derivatives as pde-5 inhibitors |
| 12/11/2002 | WO2002000231A1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 12/11/2002 | EP1264827A1 Process for the preparation of Tosylbenzylformamides |
| 12/11/2002 | EP1264597A2 Methods and compositions for treating cancer |
| 12/11/2002 | EP1263959A1 Antibodies to human cd154 |
| 12/11/2002 | EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 12/11/2002 | EP1263933A2 Treatment for bone disorders |
| 12/11/2002 | EP1263786A2 Methods and compositions for immunoregulation |
| 12/11/2002 | EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer |
| 12/11/2002 | EP1263760A1 Novel compounds |
| 12/11/2002 | EP1263759A2 Azaindoles |
| 12/11/2002 | EP1263758A2 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives |
| 12/11/2002 | EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors |
| 12/11/2002 | EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 12/11/2002 | EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 12/11/2002 | EP1263747A1 1,5-benzothiazepines and their use as hypolipidaemics |
| 12/11/2002 | EP1263736A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
| 12/11/2002 | EP1263732A1 Corticotropin releasing factor antagonists |
| 12/11/2002 | EP1263730A1 Amine derivatives for the treatment of apoptosis |
| 12/11/2002 | EP1263725A1 Novel compounds |
| 12/11/2002 | EP1263724A1 Novel compounds |
| 12/11/2002 | EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 12/11/2002 | EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 12/11/2002 | EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 12/11/2002 | EP1263718A1 Novel use of phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263715A1 Novel phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263711A1 Novel use of phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263503A2 Use of cyanoquinolines for treating or inhibiting colonic polyps |
| 12/11/2002 | EP1263472A2 Modification of biopolymers for improved drug delivery |
| 12/11/2002 | EP1263467A1 Improved paste formulations |
| 12/11/2002 | EP1263442A1 TETRACYCLINE COMPOUNDS FOR TREATMENT OF i CRYPTOSPORIDIUM PARVUM /i RELATED DISORDERS |
| 12/11/2002 | EP1263435A1 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 12/11/2002 | EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 12/11/2002 | EP1263427A1 Il-8 receptor antagonists |
| 12/11/2002 | EP1263347A2 System for the controlled delivery of an active material to a dental site |
| 12/11/2002 | EP1175149B1 Disinfecting composition based on h2o2, acids and metal ions |
| 12/11/2002 | EP1148791B1 Protein material for slow digestion and its use |
| 12/11/2002 | EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions |
| 12/11/2002 | EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 12/11/2002 | EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors |
| 12/11/2002 | EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 12/11/2002 | EP0942741B1 Lectin compositions and uses thereof |
| 12/11/2002 | EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists |
| 12/11/2002 | EP0925294B1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 12/11/2002 | EP0907632B1 Inhibition of matrix metalloproteases by substituted phenethyl compounds |
| 12/11/2002 | EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases |
| 12/11/2002 | EP0805796B1 Cell adhesion inhibitors |
| 12/11/2002 | EP0723447B1 Use of (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 12/11/2002 | CN1384839A Redox reversible HCV proteins with native-like conformation |
| 12/11/2002 | CN1384833A Synthesis and methods of use of 9-substituted guanine derivatives |
| 12/11/2002 | CN1384831A Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 12/11/2002 | CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 12/11/2002 | CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation |
| 12/11/2002 | CN1384822A Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-3,3-diphenylpropionate and use thereof endothelin antagonist |
| 12/11/2002 | CN1384750A Plant extract mixtures and their uses |
| 12/11/2002 | CN1384740A Delayed-action form of administration containing tramadol saccharinate |
| 12/11/2002 | CN1384739A Oral pharmaceutical forms of administration with a delayed action |
| 12/11/2002 | CN1384735A Oral dosage forms |
| 12/11/2002 | CN1384733A Dry powder compositions having improved dispersivity |
| 12/11/2002 | CN1384713A Dietary food supplement containing natural cyclooxygenase inhibitors |
| 12/11/2002 | CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative |
| 12/11/2002 | CN1383894A Chinese and western combined medicine for treating chronic enterogastritis and ulcer and its prepn |
| 12/11/2002 | CN1383891A Life-proloning peptide health food |
| 12/11/2002 | CN1383889A 鳄鱼丸 Crocodile pill |
| 12/11/2002 | CN1383881A Gansukang capsule |
| 12/11/2002 | CN1383876A Chinese medicine for treating hepatitis B |
| 12/11/2002 | CN1383872A Kidney-invigorating and Yang-strenghtening wine |
| 12/11/2002 | CN1383861A Buccal tablet containing healthy flavor fresh-flower factor |
| 12/11/2002 | CN1383858A Medicine for treating diseases of liver, gallbladder and spleen |
| 12/11/2002 | CN1383855A Gastropathy treating Chinese medicine |
| 12/11/2002 | CN1383850A Ganweikang tablet and its prepn |
| 12/11/2002 | CN1383838A Refreshing and brain-nourishing medicine made of American ginseng and yolk lecithin |
| 12/11/2002 | CN1383815A Compound prepn of ornithine and asparagic acid for preventing and treating hepatosis and hepatic encephalopathy and its prepn process |
| 12/11/2002 | CN1095839C 4,5-diaryl oxazole derivatives |
| 12/11/2002 | CN1095675C Medicinal plaster for curing wind-cold-dampness pathogen and traumatic injury |
| 12/11/2002 | CN1095672C Traditional Chinese medicine for treating cirrhosis and liver cancer |
| 12/11/2002 | CA2412227A1 Use of a composition consisting of or with a content of at least a dissimilated milk serum |
| 12/10/2002 | US6492552 Disulfide derivatives useful for treating allergic diseases |
| 12/10/2002 | US6492516 Pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis. |
| 12/10/2002 | US6492499 Human pancreatitis-associated protein |
| 12/10/2002 | US6492425 Inhibitors of transcription factor-NF-κB |
| 12/10/2002 | US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 12/10/2002 | US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 12/10/2002 | US6492408 Peptidomimetic inhibitors of intercellular adhesion molecules binding to leukointegrins, such as lfa-1 and mac-1 |
| 12/10/2002 | US6492406 Pharmaceutically active compounds |
| 12/10/2002 | US6492403 Methods of treating C1s-mediated diseases and conditions and compositions thereof |